LFCR (Lifecore Biomedical) Other Current Liabilities: $-6.83 Mil (As of Mar. 2026)


LFCR Lifecore Biomedical Inc LFCR
55 GF Score
Price $4.86
GF Value $6.50
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Lifecore Biomedical Other Current Liabilities?

Lifecore Biomedical LFCR -3.67% 55 Other Current Liabilities is $-6.83 Mil as of Mar. 2026. GuruFocus rates LFCR with a GF Score™ of 55/100 and a GF Value™ of $6.50 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Lifecore Biomedical's other current liabilities for the quarter that ended in Mar. 2026 was $-6.83 Mil.

Lifecore Biomedical's quarterly other current liabilities declined from Sep. 2025 ($7.02 Mil) to Dec. 2025 ($6.05 Mil) and declined from Dec. 2025 ($6.05 Mil) to Mar. 2026 ($-6.83 Mil).

Lifecore Biomedical's annual other current liabilities increased from May. 2023 ($4.15 Mil) to May. 2024 ($7.72 Mil) and increased from May. 2024 ($7.72 Mil) to May. 2025 ($7.99 Mil).

Lifecore Biomedical Other Current Liabilities Related Terms

Lifecore Biomedical Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Lifecore Biomedical's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Other Current Liabilities Chart

Lifecore Biomedical Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.40 13.69 4.15 7.72 7.99

Lifecore Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.97 7.99 7.02 6.05 -6.83
LFCR
55GF Score
Lifecore Biomedical Inc LFCR
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lifecore Biomedical Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $-6.83 Mil mean?
Lifecore Biomedical (LFCR) has a Other Current Liabilities of $-6.83 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Lifecore Biomedical.
Is Lifecore Biomedical's Other Current Liabilities too high?
Lifecore Biomedical's current Other Current Liabilities is $-6.83 Mil. Overall, Lifecore Biomedical has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lifecore Biomedical's Other Current Liabilities compare to ANIK and DERM?
Lifecore Biomedical's Other Current Liabilities of $-6.83 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Lifecore Biomedical. Lifecore Biomedical's current Other Current Liabilities is $-6.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecore Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Lifecore Biomedical (LFCR) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.50, compared to a current price of $4.86 — trading 25.2% below its estimated fair value. The current Other Current Liabilities is $-6.83 Mil. Lifecore Biomedical's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Lifecore Biomedical (LFCR), the current Other Current Liabilities is $-6.83 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecore Biomedical (LFCR) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecore Biomedical stock appears to be undervalued. The current stock price of $4.86 is trading 25.2% below its estimated GF Value™ of $6.50. GuruFocus considers Lifecore Biomedical to be Modestly Undervalued.

Key valuation signals for LFCR:

  • Other Current Liabilities: $-6.83 Mil
  • GF Value™: $6.50 vs. price of $4.86 (25.2% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the LFCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifecore Biomedical Business Description

Other Exchanges LDE:Germany
Address 3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
55GF Score

Get the complete analysis for LFCR

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.86
Price
$6.50
GF Value